About the bill
- Full Title
To provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes.
The bill’s title was written by its sponsor.
Read CRS Summary >
Jan 26, 2005
This is the first step in the legislative process.
Read Text »
Oct 19, 2007
Reintroduced Bill —
This activity took place on a related bill, S. 2210 (110th).
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 417”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
- Related Bills
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
S. 2210 (110th)
was a re-introduction of this bill in a later Congress.
Referred to Committee
Last Action: Oct 19, 2007
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 417 — 109th Congress: Medical Innovation Prize Act of 2005. Retrieved from https://www.govtrack.us/congress/bills/109/hr417
“H.R. 417 — 109th Congress: Medical Innovation Prize Act of 2005.” www.GovTrack.us. 2005. February 14, 2016 <https://www.govtrack.us/congress/bills/109/hr417>
|title=H.R. 417 (109th)
|accessdate=February 14, 2016
|author=109th Congress (2005)
|date=January 26, 2005
|quote=Medical Innovation Prize Act of 2005